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ReviewDeacetylase Enzymes: Biological Functions
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that hyperacetylated chromatin is associated with active
gene expression, presumably because of its increased
accessibility to transcription factors. The reversible
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the cell has focused on transcriptional regulation, the
dynamic acetylation and deacetylation of non-histoneIntroduction
The reversible acetylation of histones plays a critical proteins and small molecules is critical for many other
cellular processes. There is increasing evidence that therole in transcriptional regulation in eukaryotic cells, and
there is mounting evidence that acetylation of non-his- function of several other proteins is also regulated by
their acetylation state. For example, the DNA bindingtone substrates is important for other cellular processes
(reviewed in [1]). Two families of deacetylase enzymes activity of p53, E2F1, EKLF, and GATA1 is enhanced by
the acetylation of a lysine residue, and acetylation ofhave been identified: the histone deacetylases, or
HDACs, and the Sir2 (silent information regulator)-like -tubulin appears to stabilize microtubules. Thus, acet-
ylation of lysine residues and the negation of the positivefamily of NAD-dependent deacetylases, or sirtuins (re-
viewed in [2]). Both families have been evolutionarily charges associated with these side chains may be a
general mechanism for altering protein structures orconserved from prokaryotes to humans, and both con-
sist of several different proteins with nonredundant cel- protein-protein interactions, much like phosphorylation
(reviewed in 1). In addition to proteins, small organiclular functions, many of which involve transcriptional
regulation. Several processes have evolved to control molecules in the cell are also dynamically acetylated and
deacetylated. Notably, polyamines such as spermidinethe activity of deacetylases; such processes range from
the recruitment of these proteins by specific transcrip- and spermine appear to function in DNA condensation
processes as free amines and are inactivated by acetyla-tion factors to the more general inactivation of the
deacetylases by sequestration. In the case of HDACs, tion of these amine groups [5]. Hence, while it is clear
that histone acetyltransferases and histone deacety-small-molecule inhibitors have proven to be crucial for
the identification and subsequent characterization of lases are critical for the regulation of transcription, these
proteins, or unidentified proteins, undoubtedly functionthese enzymes. Structural differences among the mem-
bers of this family suggest that it will be possible to in other cellular processes as well.
develop specific inhibitors for each of these proteins,
which would be useful for elucidating their individual
The HDAC and Sirtuin Families of Deacetylasescellular functions. In the case of the sirtuins, no func-
There have been two families of deacetylases identifiedtional characterization of any of the human proteins has
in eukaryotes, the histone deacetylases, or HDACs, andbeen reported. Thus, the recent identification of a sirtuin
the Sir2-like deacetylases, or sirtuins. The HDAC en-deacetylase inhibitor [3] may provide a very powerful
zymes possess a highly conserved catalytic domain oftool for studying the biology of these enzymes.
approximately 390 amino acids and appear to deacety-
late their substrates by activating a water molecule withRegulation of Cellular Processes by Acetylation
a divalent zinc cation coupled to a histidine-aspartateEukaryotic DNA is packaged into nucleosomes, which
charge-relay system [6]. The HDAC family members canconsist of 146 base pairs of DNA wound around a core
be divided into two classes based on their similarityof eight histone proteins. These nucleosomes pack to-
to yeast histone deacetylases Rpd3 (class I) and Hda1gether to create higher-order structures to form chroma-
(class II) [7]. Four class I (HDAC1, 2, 3, and 8) and fivetin. X-ray crystallographic structural studies suggest
class II (HDAC4, 5, 6, 7, and 9) HDACs have been identi-that by protruding from the core and interacting with
fied and partially characterized in humans [2, 8], andadjacent nucleosomes, the N-terminal tails of the his-
there are potentially more deacetylases in this familytones mediate the formation of condensed chromatin
according to the genome sequence [9]. Recently, a sec-structures. Acetylation of the lysine residues in the his-
ond family of histone deacetylases, the sirtuins, wastone tails negates their positive charge, which could
identified. This group of proteins is related to the yeastresult in the destabilization of both the inter-nucleoso-
transcriptional repressor Sir2, and its members can bemal interactions and the association of the histones with
divided into five classes based on their primary structurethe negatively charged phosphate backbone of DNA.
[10]. The sirtuin deacetylases contain a conserved 275Thus, acetylation would result in the unwinding of the
amino acid catalytic domain, which is unrelated to thatnucleosomal array, which is consistent with the fact
of the HDACs, and the sirtuins operate by a very different
mechanism that requires NAD as a substrate. Despite2 Correspondence: sls@slsiris.harvard.edu
these structural and mechanistic differences, proteins3 Present address: Beckman Institute for Advanced Science and
from both families have been shown to silence transcrip-Technology, University of Illinois, Urbana-Champaign, 405 North
Mathews Avenue, Urbana, Illinois 61801. tion at specific promoters or chromosomal domains by
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localized histone deacetylation. However, it is likely that
members of the two families function in other cellular
processes with non-histone substrates.
HDAC Family Members
HDAC1 was the first histone deacetylase to be identified
and characterized. HDAC1 was isolated by affinity chro-
matography with a derivative of a natural product, tra-
poxin A, which was discovered in a phenotypic screen
involving the change in the spindle-like morphology of
v-sis-transformed NIH 3T3 cells to the flattened mor-
phology of fibroblasts [11]. Subsequently, trapoxin A
was shown to inhibit the histone deacetylase activity
[12, 13] that had been detected in nuclear extracts by
Allfrey, now more than forty years ago (reviewed in [14]).
By affinity chromatography, trapoxin A was found to
bind to a previously unidentified protein, and subse-
quent characterization of this protein led to the determi-
nation that it was responsible for the activity observed
by Allfrey [15]. This discovery of HDAC1 opened up many
Figure 1. Protein Complexes of HDAC Deacetylases
investigations of histone deacetylase function and quickly
HDAC1 and 2 are found in three main complexes, the Sin3, NuRD,
led to the observation that HDACs both deacetylate his- and CoREST complexes, which are recruited to promoters or DNA
tones in vitro and silence gene expression in vivo [15, 16]. binding domains by various proteins. HDAC1 and 2 can also be
Sequence analysis of HDAC1 revealed that it was the recruited directly by certain transcription factors. HDAC3, 4, 5, and
7 directly associate with the nuclear corepressors NCoR and SMRT,human homolog of the yeast protein Rpd3 (reduced
and with each other. HDAC4, 5, and 7 can also interact directly withpotassium dependency), a known transcriptional regula-
members of the MEF2 family of transcription factors.tor. Subsequent fractionation of the histone deacetylase
activity in yeast yielded at least two distinct protein
complexes, one of which contained Rpd3, and the other
insects to human suggests that these enzymes performof which contained a highly related protein, Hda1. Hda1
critical nonredundant functions.contains the conserved HDAC catalytic domain and pos-
sesses deacetylase activity, but it is significantly larger
in size than Rpd3. The eight cloned human HDACs Protein Complexes of HDACs
HDAC1 and HDAC2 are the best characterized of theclearly fall into two separate classes by primary struc-
ture and size: those with homology to Rpd3, or the class HDAC proteins and are generally found in stable, multi-
component complexes of proteins, which are then re-I HDACs (HDAC1, 2, 3, and 8), and those with greater
similarity to Hda1, or the class II HDACs (HDAC4, 5, 6, cruited by DNA binding proteins (Figure 1). Three com-
plexes containing HDAC1 and HDAC2 have been7, and 9) (reviewed in [2]). All of these HDACs contain
the conserved catalytic domain and possess in vitro characterized thus far: the Sin3, NuRD, and CoREST
complexes. A “core complex,” consisting of HDAC1/2histone deacetylase activity, but the class II proteins are
two to three times larger in size than the class I proteins. and the histone binding proteins RbAp46/48, has been
described; this complex stabily associates in vivo andFurthermore, there are certain conserved sequence mo-
tifs in the catalytic domain that differ between the two in vitro [20]. The Sin3 complex consists of this core
complex, along with SAP18 and SAP30, which appear toclasses [7].
These two classes of HDACs appear to have diverged aid in stabilizing the protein associations, and mSin3A,
which serves as a scaffold for the assembly of the com-early in evolution and to have been conserved in a wide
variety of eukaryotes. A comparison of the human and plex and its interaction with various DNA binding pro-
teins (reviewed in [21]). The NuRD complex (nucleoso-yeast HDAC sequences with those of the eubacterium
Bacillus subtilis acetoin utilization protein (AcuC) and mal remodeling and deacetylation) also contains the
core complex, as well as MTA2, which is related to athe proteobacterium Mycoplana ramosa acetylspermine
deacetylase (ASD) reveals that these proteins contain protein (MTA1) found to be overexpressed in metastatic
tumor cells, and CHD3 and CHD4 (also called Mi-2features present primarily in class I and class II HDACs,
respectively. Both enzymes are postulated to catalyze and Mi-2), which possess the DNA helicase/ATPase
domains found in the SWI/SNF family of chromatin re-deacetylation of their substrates [17–19], further strength-
ening the evolutionary and functional link between these modeling proteins (reviewed in [22]). The coupling of
chromatin remodeling and deacetylase activity may playproteins and HDACs. This suggests that ASD and AcuC
may have diverged from a common ancestor and subse- an important role in the deacetylation of chromatinized
histones in the cell; although histones can be deacety-quently evolved to give rise to the two classes of eukary-
otic HDACs that comprise the HDAC family [7]. The two lated by HDAC1 in the absence of ATP, ATP hydrolysis,
and presumably chromatin remodeling, is required forclasses of HDACs have been maintained in other higher
eukaryotes as well, including C. elegans and Drosophila. the deacetylation of oligonucleosomes in vitro [23, 24].
Unlike the other two complexes, the CoREST complexThe evolutionary conservation of these proteins from
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contains HDAC1 and HDAC2 but, surprisingly, does not tion such that it exchanges the HDAC complex for a
histone acetyltransferase complex. Thus, the genes reg-appear to include RbAp46 or RbAp48. It also contains
a protein homologous to MTA1 and MTA2, termed ulated by these nuclear hormone receptors shift from a
silent state to one of active expression upon the additionCoREST, which is competent to recruit HDAC1/2 and
silence expression from a reporter gene. CoREST con- of a small-molecule ligand (reviewed in [4]). Alternatively,
the NuRD complex is recruited by the polycomb andtains two 50 amino acid SANT domains, which resemble
the DNA binding domains of Myb-related DNA binding hunchback repressors, which are involved in silencing
gene expression from clusters of homeotic genes. Givenproteins. MTA1 and MTA2 also contain SANT domains,
as do several other proteins involved in transcriptional these observations, it is hypothesized that the Sin3 com-
plex is involved in silencing specific genes, whereasregulation. Such proteins include SWI3, ADA3, NCoR
and TFIIIB, for which SANT is named [25]. These SANT NuRD silences large chromosomal domains by a mecha-
nism that may require its chromatin remodeling activitydomains may mediate critical protein-protein interac-
tions; indeed, the N-terminal SANT domain of CoREST (reviewed in [22]). However, there are cases in which
transcription factors recruit multiple HDAC complexes.is required for the recruitment of HDAC1 to promoters
[26]. Another member of this complex is p110, which For example, Ikaros, a protein involved in lymphoid cell
development and T cell activation, can bind to bothcontains an FAD binding domain and is homologous to
polyamine oxidases, although enzymatic activity has not Sin3 and NuRD (reviewed in [22]), whereas REST, which
silences neuronal-specific genes in non-neuronal cellsyet been demonstrated for this protein [26, 27]. However,
treatment of cells with [3 H]-riboflavin, a precursor to (reviewed in 39), can bind to both the Sin3 and CoREST
complexes [40–43]. Additionally, both the Sin3 andFAD, does result in the purification of radioactivity with
the CoREST complex, suggesting that FAD does indeed NuRD complexes have been shown to associate with
different members of the methylated DNA binding pro-bind to p110 [27]. Interestingly, the sirtuin family of
deacetylases requires NAD as a substrate in order to tein family (reviewed in [22]).
A third mechanism for regulating HDAC activity in-deacetylate lysine residues (see below). Thus, there is
a provocative link between redox cofactors and histone volves blocking the binding of an HDAC to a transcrip-
tion factor. Such a mechanism regulates the interactiondeacetylase activity, and these cofactors may play criti-
cal roles in transcriptional regulation. between HDAC4 and MEF2 [44]. HDAC4 and the histone
acetyltransferase p300 compete for the same bindingThe other HDACs have also been found in complexes
with HDACs or with corepressor proteins. HDAC4 asso- site on MEF2; thus, altering the binding partner allows
MEF2 to switch from silencing to activating gene expres-ciates with RbAp48, whereas HDAC5 does not seem
to associate with this protein. HDAC3 associates with sion. The MEF2 binding site on HDAC4 overlaps with a
calmodulin binding site, and in the presence of calcium,HDAC4 and HDAC5, and it might associate with HDAC7,
given that this protein is highly homologous to HDAC4 HDAC4 binds to calmodulin, loses its interaction with
MEF2, and thereby allows MEF2 to recruit p300 (Figureand 5 [7]. Furthermore, all four of these HDACs have
been shown to associate directly with the corepressors 2). Interestingly, the N-terminal domain of HDAC4/5/7
can slightly inhibit MEF2 transcription in the absence ofNCoR and SMRT [28–32]. Additionally, HDAC4, 5, and
7 contain common N-terminal extensions, which interact the deacetylase catalytic domain [33, 35, 44, 45]; this
may be due to its ability to block p300 binding. A proteindirectly with the MADS box domain of the MEF (myocyte
enhancing factor) family of transcription factors [33–35]. with homology to the N-terminal domains of HDAC4 and
5 but without any catalytic domain has been identified.
It is possible that this protein functions as a dominant-
Regulation of Transcriptional Silencing by HDACs negative version of HDAC4 and 5 by blocking its binding
In order for transcription to be silenced, HDACs must to protein partners [46].
be targeted to the promoter regions of genes because The fourth mechanism for regulating HDAC activity
they cannot directly interact with DNA or histone pro- involves sequestration of HDACs in an extranuclear
teins. Four mechanisms for regulating HDAC activity in compartment. This method of regulation thus operates
the cell have been described (reviewed in [36, 37]). The at a higher level than the previously described mecha-
first three mechanisms involve recruiting HDACs to nisms. This process has been characterized for the class
genes via interactions with specific DNA binding pro- II HDACs 4, 5, and 7 (Figure 2). These HDACs can be
teins, whereas the fourth mechanism involves a higher- phosphorylated at serine residues at three 14-3-3 bind-
order regulatory system in which HDACs are inactivated ing sites in their N-terminal domains. This phosphoryla-
by sequestration. In the simplest case, HDACs can di- tion both disrupts the HDAC-MEF interaction [47] and
rectly interact with a DNA binding protein that specifi- allows binding of 14-3-3, which occludes an importin
cally associates with a set of promoters. For example, binding site and results in the shuttling of the HDACs
HDAC1 appears to interact directly with the transcription out of the nucleus into the cytoplasm, where they are
factor YY1 [38], whereas HDAC4, 5, 7, and 9 bind to the presumably held in an inactive state with respect to
MEF family of transcription factors. The second mecha- transcriptional regulation [48]. After the release of the
nism is similar, but in this case a complex of HDAC HDAC proteins, MEF can recruit a histone acetyltrans-
proteins can be recruited by a DNA binding protein, via ferase complex and activate the transcription of genes
interactions between this protein and other members of required for muscle differentiation. Thus, upon induction
the complex. For example, the Sin3 complex is recruited of differentiation of myoblasts into myotubes by serum
by nonliganded nuclear hormone receptors. When the starvation, HDAC4, 5, and 7 shuttle out of the nucleus
[33, 49], and histones in the promoters of the MEF-hormone ligand binds, the receptor alters its conforma-
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Figure 2. Model for Regulation of HDAC4, 5, and 7 Transcriptional Silencing Activity
In proliferating myoblasts, the MAPK signaling pathway is activated, and HDAC4, 5, and 7 are localized to the nucleus, where they interact
with HDAC3 and inhibit MEF2 transcriptional activity. Upon the induction of differentiation to myotubes, the HDACs dissociate from MEF2,
either because of phosphorylation by CaMKI signaling (A) or because of the binding of calmodulin (CaM) (B). HDAC is sequestered in the
cytoplasm by 14-3-3 proteins, and MEF2 recruits the histone acetyltransferase p300 to activate gene expression.
regulated genes become acetylated [50], which is corre- and aspartate residues (Figure 3). The channel leading
to the active site is surrounded by hydrophobic residues,lated with the expression of these genes.
This shuttling process appears to be regulated in part which is presumably where the aliphatic chain of the
acetyl-lysine residue is nestled.by CaMKI (Ca2/calmodulin-dependent kinase I) be-
cause overexpression of CaMKI causes cytoplasmic lo- The cocrystallization of TSA with HDLP allows for an
analysis of the structural properties of these HDAC in-calization of HDAC4/5 and CaMKI can phosphorylate
HDAC5 in vitro. Mutation of the 14-3-3 binding sites in hibitors. TSA contains a cap group, an aliphatic chain,
and a terminal hydroxamic acid functional group (FigureHDAC5 prevents dissociation of HDAC5 and MEF upon
CaMKI overexpression [47] and blocks myogenesis [49].
Interestingly, a second type of phosphorylation seems
to be required to shuttle HDAC4 into the nucleus. It has
recently been shown that HDAC4 is associated with
ERK1/2 kinases and can be phosphorylated by them in
vitro. Activation of the Ras-MAPK (mitogen-activated
protein kinase) signal transduction pathway causes an
increased nuclear localization of HDAC4 [51]. Notably,
ERK1 and 2 have been implicated in the repression of
myoblast proliferation by growth factors [52], and thus
the CaMKI and MAPK signaling pathways may control
muscle differentiation via their competing effects on
HDAC localization.
Mechanism of Deacetylation by HDACs
In 1999, the crystal structure of a bacterial HDAC homo-
log, HDLP (histone-deacetylase-like protein), bound to
an HDAC inhibitor, trichostatin A (TSA), was reported
[6]. The catalytic domain of HDLP is very closely related
to those of both classes of HDACs, and thus the mecha-
nism of deacetylation is presumably conserved as well.
HDLP has a single domain structure related to the open
/ class of folds. It contains a central eight-stranded
parallel  sheet, with four  helices packed on either
Figure 3. Structure of HDLP Active Site Bound to Trichostatin Aface. Eight additional  helices and large loops in the
The hydroxamic acid functional group of TSA coordinates the zinc sheet further extend the structure and result in the
cation and makes hydrogen bonds (shown as dashed lines) to sev-formation of a deep, narrow pocket with an adjacent
eral amino acids in the active site. The aliphatic chain of TSA makesinternal cavity. TSA binds to this pocket, which thus
van der Waals contacts (thatched semi-circles) with the residues
represents the active site of the enzyme. HDLP requires lining the channel, and the cap group of TSA interacts with proline
Zn2 for activity; this cation is positioned near the bottom 22 and tyrosine 91 of HDLP. Notably, Y91 is the only residue whose
conformation is altered upon TSA binding [6].of the pocket and is coordinated by several histidine
Review
7
Figure 4. Proposed Mechanism for HDAC Deacetylation
The HDLP-mediated deacetylation of an acetylated lysine residue is depicted above. A bound water molecule is activated by both the zinc
cation and a histidine-aspartate charged relay system to attack the amide bond. The oxy-anion intermediate is stabilized by the zinc cation
and an adjacent tyrosine residue. As this intermediate collapses, the carbon-nitrogen bond breaks, and the nitrogen accepts a proton from
an activated histidine residue [6].
3). The hydroxamic acid coordinates the zinc cation in lysine products. Note that this mechanism requires that
the zinc ion function in coordinating both the water mole-a bidentate fashion and hydrogen bonds with some of
the active site residues. Fitting snugly into the channel, cule and the carbonyl oxygen. The geometry of electro-
static interactions in this system makes it unlikely thatthe aliphatic chain makes several van der Waals con-
tacts with the channel residues. The cap group contacts the zinc can coordinate both molecules, and indeed, most
metal-dependent proteases use the metal ion either toresidues on the rim of the pocket and possibly mimicks
the amino acids adjacent to the acetylated lysine residue activate the water or to stabilize the oxy-anion intermedi-
ate (G.L. Verdine, personal communication). Thus, it isin the histone. The binding of TSA causes a conforma-
tional change in a tyrosine residue on this rim (tyrosine likely that zinc ion either coordinates the water molecule
or stabilizes the oxy-anion intermediate, whereas the other91) and thereby allows tighter packing of the cap group.
The proposed mechanism for the deacetylation reac- process is carried out by interactions with the amino
acid residues in the active site of the enzyme.tion is similar to that seen in metallo- and serine prote-
ases (Figure 4). The carbonyl oxygen of the N-acetyl
amide bond is thought to coordinate to the zinc cation Structural Differences of the Human HDACs
The catalytic domains of the nine known human HDACsand to thereby position it closely to a bound water mole-
cule and activate it for a nucleophilic attack by the water. are very well conserved, but there are certain differences
that may allow for the production of specific inhibitors.The nucleophilicity of the water molecule, in turn, could
be enhanced by an interaction with the negatively Most of the residues that are seen in the HDLP structure
to interact directly with TSA are completely conservedcharged histidine-aspartate pair, and it is proposed to
be oriented by coordination to the zinc ion. Attack of among all of the HDACs, but there is less conservation
in the surrounding residues, with significant differencesthe water molecule on the carbonyl carbon would pro-
duce an oxy-anion intermediate, which is possibly stabi- apparent between the class I and class II HDACs (Figure
5). Notably, there is a striking divergence in the regionlized by the zinc ion and by hydrogen bonding to a
nearby tyrosine. The collapse of this intermediate would of tyrosine 91 of HDLP, and this tyrosine residue itself
is very poorly conserved among the human HDACs. Thisresult in cleavage of the carbon-nitrogen bond, with the
nitrogen accepting a proton from the histidine residue, is particularly interesting in that tyrosine 91 is positioned
on the rim of the channel and interacts directly with theand would thereby produce the observed acetate and
Chemistry & Biology
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Figure 5. Partial Sequence Comparison of the HDAC Family Members
The catalytic domain of HDLP was aligned with those of HDACs 1–8, and the regions surrounding the active site were analyzed. The residues
of HDLP directly interacting with TSA are labeled and are colored in gray when they are conserved among the other HDACs. Adjacent residues
that differ between the class I and class II HDACs are boxed. Note that there are several sequence differences in these areas among the
eight HDACs, particularly in the vicinity of tyrosine 91 of HDLP (GenBank Accession Numbers: HDAC1 Q13547, HDAC2 Q92769, HDAC3
NP_003874, HDAC4 AAD29046, HDAC5 AAD29047, HDAC6 AAD29048, HDAC7 NP_056216, and HDAC8 AAF73428; not shown: HDAC9
AAK66821).
cap group of TSA, and it is the only residue that shifts appear to form covalent bonds with active site residues
[54] that are irreversible under native conditions.its conformation upon TSA binding [6]. Thus, the consid-
erable diversity in the region of the protein suggests Two types of cap groups are found in natural HDAC
inhibitors, either a small planar group (as in trichostatinthat it will be possible to develop specific inhibitors by
altering the structure of this cap group.
Synthetic HDAC Inhibitors
Several non-natural inhibitors of histone deacetylases
have been synthesized, and analysis of these will facili-
tate the discovery of specific inhibitors. The basic struc-
ture of these small molecules mimics that of TSA in that
they possess a cap group, an aliphatic chain, and a
functional group that would chelate the metal cation in
Figure 6. Structural Properties of HDAC Inhibitorsthe active site (Figure 6). The experimentally determined
Trichostatin A contains a hydroxamic acid functional group thatoptimal length for the aliphatic chain is five to six carbon
chelates the zinc cation in HDAC and makes hydrogen bonds toresidues, with inhibitory activity decreasing rapidly for
various amino acids in the active site. The aliphatic chain mimicslonger and shorter chains [53]. There are several possi-
that of lysine and forms van der Waals interactions with the residues
ble functional groups, hydroxamic acids [53–56] and lining the channel. Note that the optimal chain length is 5–6 carbon
phenylene diamines [57], which presumably reversibly residues. Finally, the cap group interacts with the residues around
the rim of the channel.coordinate the zinc cation, as well as epoxides, which
Review
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A) or a cyclic tetrapeptide group (as in trapoxin A). Inter- Protein Complexes and Cellular Functions
of Sirtuinsestingly, the type of cap group alters the ability of the
compound to inhibit HDAC activity in vitro. Molecules Yeast Sir2 is the best-characterized sirtuin protein. It
was originally identified in a screen for mutants thatwith a small cap group are not active if the functional
group is a carboxylic acid [53], whereas molecules with disrupted the transcriptional silencing of the HM loci in
yeast [62, 63], and it has since been shown to be involveda cyclic tetrapeptide cap group and a carboxylic acid
functional group are potent inhibitors [54]. in silencing gene expression at telomeres and rDNA
locus as well (Figure 7). Sir2 is found in two major com-
plexes, one of which is responsible for silencing expres-Generation of Specific HDAC Inhibitors
sion from the telomeric and HM loci (Sir2, Sir3, and Sir4),Specific HDAC inhibitors would be extremely valuable,
and a second that suppresses genetic recombinationboth as tools for probing the biological functions of
by forming a closed chromatin structure at the rDNAthese different enzymes and for therapeutic purposes,
locus (Sir2, Net1, Cdc14) (reviewed in [64]).such as inhibiting a specific HDAC that is associated
When tethered to telomeric loci, Sir2 performs severalwith a particular disease. The structural differences in
functions aside from silencing gene expression. Telo-the active sites of the HDACs is encouraging in this
meric Sir2 is required for the maintenance of genomicregard. Indeed, alterations in the structure of the cap
integrity and may play a role in the DNA damage re-group have led to specific inhibitors of HDACs in two
sponse. Deletions of Sir3 or Sir4 result in a shortening ofcases. First, N-alkylations of the indole residue in the
the telomeres and loss of chromosomes during mitosis.cap group of apicidin has led to the development of
Furthermore, overexpression of Sir4 results in an in-apicidin derivatives that are approximately 20-fold more
crease in telomere length, suggesting that the Sir2/3/4potent as inhibitors of malarial HDACs than is human
complex plays a direct role in stabilizing telomeres inHDAC1 [58]. Secondly, HDAC6 is not inhibited by any
yeast [65]. Additionally, a fraction of the telomeric Sir2/of the cyclic tetrapeptide inhibitors, even when a hydrox-
3/4 complex is bound there by the Ku70/80 heterodimeramic acid is used as a functional group [54]. Notably,
(Figure 7). Upon double-stranded DNA break formation,HDAC6 has the greatest divergence from the other HDACs
Ku relocates to the damaged sites in a Mec1-dependentin the rim region surrounding tyrosine 91 in HDLP. Thus,
manner and subsequently recruits telomeric Sir3, Sir4,it should be possible to generate specific inhibitors of
and possibly Sir2 to these sites. Indeed, DNA damagethe HDAC family of histone deacetylases by creating
has been shown to derepress telomeric genes, presum-biased combinatorial libraries containing an aliphatic
ably by the movement of the Sir2/3/4 complex from thechain and terminal functional group attached to diverse
telomeres to damaged regions of the genome [66–69].capping groups.
Thus, the telomere may serve as a resevoir for Sir2
proteins that can be mobilized to sites of DNA damage
Sirtuin Family Members when necessary.
Members of the sirtuin family of histone deacetylases At the rDNA locus, yeast Sir2 inhibits genetic recombi-
possess several conserved sequence motifs. The cata- nation and thereby modulates life span. The rDNA locus
lytic domain consists of approximately 275 amino acids consists of 100 to 200 copies of genes encoding rRNA
and contains two sets of CXXC motifs, which may func- and thus is prone to high recombination frequencies.
tion as zinc finger domains [59], as well as one or more The frequency of these recombination events is reduced
hydrophobic regions that may function as leucine zip- by the formation of a hypoacetylated, condensed chro-
pers [60]. Both of these types of domains could mediate matin structure by Sir2. Furthermore, nucleolar Sir2 also
protein-protein or protein-DNA interactions, although binds to Pch2, a protein required for meiotic pachytene
there is no evidence for the latter activity in any of the checkpoint, which inhibits recombination at the rDNA
sirtuins. There are several other short conserved se- locus during meiosis [70]. Additionally, nucleolar Sir2
quences in this domain as well, and mutation of some also appears to be in a complex with Cdc14, a phospha-
of these have been shown to abrogate catalytic activity tase that is required for passage through telophase (Fig-
[59, 61]. ure 7) [71] and which must be released from the nucleo-
Several sirtuins have been identified in prokaryotes lus at the end of mitosis in order for the cell cycle to
and eukaryotes, and these can be divided into five proceed. Interestingly, Sir2 is also released from the
classes based on sequence homology. S. cerevisiae has rDNA locus at mitosis, but the function of this is unknown
five sirtuins, including the founding member, Sir2, and [72]. Sir2 will also silence reporter genes with weak pro-
four homologs, Hst1–4 (homolog of Sir two). Four sirtuins moters that have been inserted into the rDNA locus
have been identified thus far in C. elegans, and five in [73, 74].
Drosophila. Seven sirtuins (SIRT1-7) have been identi- Sir2 has been linked to aging in yeast, and this is
fied in humans. Several bacterial species, including E. thought to be mediated by its NAD dependence and its
coli, Streptomyces, and Bacillus subtilis, have sirtuins repression of rDNA recombination (Figure 8, reviewed
as well. All five yeast sirtuins are class I proteins, as are in [75]). As previously discussed, acetylation and chro-
human SIRT1, 2 and 3. SIRT4 is a class II sirtuin, SIRT5 matin decondensation at the rDNA locus leads to in-
is in class III, and SIRT6 and SIRT7 are class IV proteins. creased recombination rates in this region. Because of
There are no class I or IV sirtuins in prokaryotes, and thus the large arrays of repeated DNA sequences, this allows
these sirtuins may represent the most recently evolved the rDNA repeats to be spliced out, producing extra-
members of this family, whereas most bacterial sirtuins chromosomal circles (ERCs). ERCs accumulate in older
yeast cells and have been found to decrease yeast lifeare of the class III variety [10].
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Figure 7. Complexes of Sir2
Various DNA binding proteins recruit the intracellular pool of Sir2 to the telomeric and silent mating loci (HMRE is shown here) as a complex
with Sir3 and Sir4. Upon DNA damage, the Ku heterodimer relocates from the telomeres to the damaged regions and recruits Sir3/4 and,
presumably, Sir2. At the rDNA locus, Sir2 is associated with Net1, Pch2, and Cdc14. At the end of mitosis, Sir2 and Cdc14 are released from
the nucleolus.
span when artificially introduced. Loss of function muta- the metabolic rate. Thus, increases in glucose intake
lead to increased metabolism, which results in a reduc-tions or deletions of Sir2 causes an increase in ERC
formation as well as a decrease in life span, whereas the tion of NAD to NADH. This decrease in the amount of
available NAD decreases Sir2 activity and increases re-addition of an extra copy of Sir2 results in a substantial
increase in life span. Notably, a deletion of a protein combination rates and the formation of toxic ERCs,
which accumulate in the nucleus of the mother cell andresponsible for recombination at the rDNA locus will
rescue the decreased life span and increased frequency lead to a shortened life span (Figure 8). The critical role
of NAD levels in this process is evident from the factof ERCs found in Sir2 mutants, suggesting that in-
creased recombination is indeed the main deleterious that mutations in an NAD biosynthetic pathway in yeast
lead to a decrease in life span that is not rescued byfactor [76].
It has also been shown that starvation or glucose mutation in the glucose-sensing pathways or Sir2 [77].
Notably, the accumulation of ERCs is not apparent dur-deprivation leads to an increased life span for a variety
of organisms. Indeed, mutation of a glucose-sensing ing the aging of other metazoan cells, although there is
evidence for a decreased expression of neuronal rRNApathway in yeast causes an increase in life span, and
this is not further enhanced by overexpression of Sir2, due to a loss of rDNA genes during aging in mammals
(reviewed in [78]). However, in these cases, loss of Sir2suggesting that they function on the same pathway [77].
Since NAD levels are closely linked to metabolic activity activity could lead to altered expression of sets of genes
that are critical for the maintenance of the cell, whichin the cell, it is hypothesized that Sir2 is regulated by
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Figure 8. Model of the Regulation of Life
Span by Sir2
Nucleolar Sir2 inhibits recombination at the
rDNA locus and thereby inhibits the formation
of toxic extrachromasomal rDNA circles. In-
creased metabolic levels due to increased
caloric intake have also been shown to de-
crease life span, and it is thought that this is
mediated by the effects of NAD levels on Sir2
activity.
could lead to the onset of senescence and death (re- formly distributed, mSIRT3 was concentrated to areas
in the region of the Golgi and ER membranes, consistentviewed in [75]).
The other yeast sirtuins also appear to have roles in with it containing a predicted transmembrane domain
[82]. No characterization of SIRT4–7 has been reported,regulating transcription, modulating cell cycle progres-
sion, maintaining genomic integrity, and DNA damage although SIRT5 is predicted to be mitochondrial based
on its sequence, whereas SIRT6 and 7 contain nuclearrepair. Hst1 is the closest Sir2 homolog in yeast and is
recruited by the DNA binding protein Sum1 to promoters localization sequences [83]. Thus, whereas SIRT1, 6,
and 7 may be directly involved in transcriptional regula-of meiosis-specific genes to repress expression of these
genes during vegetative growth [79]. Hst2 is a cytosolic tion, the four other human sirtuins presumably function
in other processes.protein and therefore probably is not directly involved
in transcriptional regulation unless it can be shuttled into Partial characterization of the mouse and Drosophila
sirtuins suggest that these proteins function in transcrip-the nucleus under certain conditions. It cannot restore
silencing in a Sir2 deletion strain, but overexpression tional regulation. Mapping of the binding sites of the
Drosophila Sir2 homolog by microarray analysis re-in a Sir2 strain enhances rDNA silencing and inhibits
telomeric silencing. Since this phenotype is also ob- vealed that this protein is associated with promoters of
active genes such as -tubulin and not with the rDNAserved when Sir2 itself is overexpressed, it has been
suggested that Hst2 and Sir2 use a common substrate cluster [84]. Thus, this sirtuin may actually be involved
in activating gene expression. Additionally, mouse Sir2athat is depleted by overexpression of either of these
proteins. Notably, overexpression of Hst2 containing a can deacetylate TAFI68 and thereby repress RNA poly-
merase I transcription in vitro. Thus, this sirtuin maypoint mutation that destroys catalytic activity still dis-
rupts telomeric and rDNA silencing, and thus NAD is not repress transcription through deacetylation of a non-
histone substrate [85].the limiting factor. Furthermore, since Sir4 is delocalized
from the telomeres upon overexpression of Sir2, but not
Hst2, it does not appear that the core Sir2/3/4 complex Regulation of Transcriptional Silencing by Sir2
Regulation of transcriptional silencing by Sir2 is similaris involved [80]. Hst3 and Hst4 are less closely related
to Sir2, but a hst3hst4 double deletion is defective in to that observed in the HDAC family of histone deacety-
lases in that Sir2 must be initially recruited to a specifictelomeric silencing. Furthermore, these double mutants
also show an increased sensitivity to UV damage and promoter or to chromosomal domains via DNA binding
proteins. However, Sir2 complexes can also spread tohave a higher rate of chromosomal missegregation. Ad-
ditionally, these cells arrest in G2/M. This suggests that adjacent chromosomal domains, which has not yet been
observed for the HDACs. Finally, Sir2 is generally regu-Hst3 and Hst4 may function redundantly in pathways
required for ensuring genomic integrity and cell cycle lated in a higher order manner similar to the class II
HDACs in that it is inactivated by sequestration withincheckpoints [60]. Thus, although mutations or deletions
of all of the known homologs of Sir2 in yeast effect the nucleus.
Telomeric and HM loci silencing appear to proceedtranscriptional regulation, some appear to have sepa-
rate primary functions. by the same mechanism, in which the Sir2/3/4 complex
is initially recruited by a DNA binding protein and thenNo cellular function has been assigned to any of the
seven known human sirtuins. SIRT1 is the closest homo- spreads to and silences the adjacent chromatin. At telo-
meres, Rap1 (repressor activator protein) binds to a 300log of yeast Sir2, both because of its primary structure
and because it contains a nuclear localization sequence base pair region containing C1–3A repeats at the ends
of telomeres, then recruits the Sir2/3/4 complex via its[10]. SIRT2 appears to be most closely related to Hst2,
and indeed it is also localized to the cytoplasm [81]. In interactions with Sir3 and Sir4. The Sir2/3/4 complex
then spreads an additional 2–4 kb along the adjacentthe mouse, mSIRT2 and mSIRT3 were both found to
localize in the cytoplasm, but whereas mSIRT2 was uni- chromatin. This spreading process occurs because of
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interactions between Sir3/4 and the tails of histones found that the acetyl group of lysine is transferred di-
rectly to the ACP-ribose molecule formed by the hydro-H3 and H4, as well as interactions between the Sir3/4
proteins in adjacent complexes (reviewed in [85]). There lysis of the nicotinamide, resulting in the production of
an O-acetyl-ADP-ribose molecule. The position at whichis some evidence that the acetylation state of the chro-
matin may be involved in the spreading of the Sir2 com- the acetyl group is attached has not been determined
yet, but it is anticipated that the hydrolysis of NAD pro-plex. Chromatin immunoprecipitation experiments have
shown that lysine 12 of histone H4 is specifically acet- ceeds via an oxocarbenium ion ADP-ribose intermedi-
ate, and thus the acetyl group may be transferred to theylated in these transcriptionally silent regions, whereas
lysines 5, 8, and 16 are not acetylated. If all four lysines ribose ring (Figure 9; [96, 97]).
Since the HDACs require only a metal to activate aare mutated to arginine in vivo, mimicking hypoacetyla-
tion, silencing is abrogated [87]. Since hypoacetylation water molecule to catalyze the deacetylation reaction,
it is interesting to speculate as to why the sirtuins requireis normally associated with silent chromatin, this obser-
vation suggests that acetylation at lysine 12 may be the cleavage of the nicotinamide ribose glycosidic bond
of NAD. The energy released by this cleavage may berequired for the spreading and silencing activity of this
deacetylase complex. Notably, Sir3 cannot bind to his- necessary to surmount an unusually large kinetic barrier
in this particular deacetylation reaction, or it may betone H4 if both lysine 12 and lysine 16 are mutated to
glutamine, mimicking acetylation at these sites [88]. This used to drive another process, such as chromatin re-
modeling. It is possible that this is simply due to thesuggests that lysine 12 should be acetylated and lysine
16 should remain unacetylated in order for the Sir2/3/4 evolution of Sir2 deacetylase activity from an ancestral
protein, in which NAD hydrolysis may have served acomplex to spread. Hence, according to this model, a
specific pattern of charges on the histone tails may be different purpose, or it may serve a relevant function in
the cell. For example, the 1-O-acetyl ADP ribose mole-required for spreading of the Sir 2/3/4 complex.
As is the case with the class II HDACs, Sir2 transcrip- cule may be a signaling molecule for an unidentified
receptor, or Sir2 may be sensing the levels of NAD intional silencing activity is more generally regulated by
sequestration. There is a limiting pool of Sir2 in the cell, the cell and regulating transcription accordingly [92].
The unusual mechanism that has been elucidated re-and this is shifted between the different loci so that it
regulates their expression in a concerted manner. It has veals that NAD serves as a true stoichiometric cofactor
rather than as a component of the catalytic machinerybeen hypothesized that Sir2 is stored at the telomere
until it is required for silencing at other loci, at which or as an allosteric regulator of the enzyme. Thus, levels
of NAD in a cell are related in a 1:1 manner to the amountpoint it moves from the telomeres to these other chromo-
somal domains. In support of this model, deletion of the of Sir2-based deacetylation. This mechanism correlates
well with the proposed link between Sir2 deacetylaseC-terminal domain of Sir4 will cause a derepression of
telomeric genes and an enhanced repression of rDNA activity and metabolic levels; if Sir2 used NAD only as
an element of the catalytic machinery, one molecule ofloci genes [89]. Deletion of Rap1 will enhance repression
of artificial reporter genes that have been inserted into NAD could be used to deacetylate many molecules of
the acetyl-lysine substrate. In this case, NAD would notinternal regions of the chromosome that are not usually
silenced [90]. This shifting of Sir2 from telomeric loci to be limiting for the reaction, and the cellular levels of
NAD would be less effectively related to the amount ofthe rDNA locus, as well Sir3 and Sir4 recruitment by Ku
proteins from the telomeres to sites of DNA damage, has Sir2 activity. However, with NAD actually serving as a
substrate, only one acetyl-lysine residue can be deacet-led to the suggestion that the main role of the telomere is
to sequester limiting pools of Sir proteins and to thereby ylated for each NAD molecule, and hence the amount
of Sir2 activity would be tightly linked to the cellularregulate gene expression [91].
NAD concentrations and thus to the metabolic state of
the cell. With this mechanism, Sir2 truly would function
Mechanism of Deacetylation by the Sirtuins as a sensor for NAD levels and metabolic activity.
Recently, Sir2 has been shown to possess NAD-depen-
dent histone deacetylase activity (reviewed in [92; 61,
93, 94]). It seems likely that this HDAC activity is respon- Crystal Structure of Sir2 Homolog
The crystal structure of a Sir2 homolog from Archaeoglo-sible for Sir2’s ability to silence gene transcription since
the regions regulated by Sir2 are hypoacetylated [87] bus fulgidus, Sir2-AF1, bound to NAD has recently been
solved [98]. This protein cannot deacetylate histones inand since deletion of Sir2 results in a dramatic increase
in the acetylation of the histones at these sites, whereas vitro, but it is competent to deacetylate BSA. Sir2-Af1
consists of a small and large domain, connected by aoverexpression of Sir2 results in substantial global
deacetylation [95]. Sir2 must cleave one molecule of large loop. The protein was crystallized in two distinct
forms, differing mainly in the structure of the loop, sug-NAD for each molecule of acetyl lysine that is deacety-
lated, and the kinetics for the hydrolysis of nicotinamide gesting that is it fairly flexible in solution. The loop covers
the pocket between the two domains, where the NADfrom NAD are very close to those observed for the
deacetylation reaction, suggesting that these reactions molecule is bound. In one crystal form, the loop is close
to the pocket, while in the other it shifts to render theare tightly linked [96]. Furthermore, Sir2 will not hy-
drolyze the glycosidic bond of NAD in the absence of pocket more accessible. Two main structural motifs are
found in Sir2-AF1. In the small domain, two pairs ofacetyl lysine, suggesting either that both substrates
must be bound to the active site or that the deacetylation cysteines bind to a zinc ion. Unlike the zinc ion in the
HDAC structure, this zinc is too far removed from theis necessary for NAD hydrolysis. Furthermore, it was
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Figure 9. Proposed Mechanism for Sirtuin Deacetylation
During the deacetylation process, the nicotinamide group from NAD is hydrolyzed, presumably forming an oxo-carbenium intermediate. The
acetyl group is then transferred to the ADP-ribose molecule. One possible mechanism for this is shown above [96].
presumed active site to participate directly in catalysis, NAD intermediate could then be cleaved by a water
molecule that is bound to the C site. This would producebut it seems to be necessary for the structural integrity
of the protein since zinc chelators inhibit enzymatic ac- the postulated oxo-carbenium ion intermediate, which
could swing back into the B site and participate in thetivity. NAD is bound in the pocket between the two
domains, at a Rossmann fold in the large domain. It deacetylation reaction [98].
is bound in an extended conformation, typical of that
observed in other proteins with Rossman folds, but its Small-Molecule Modulators of Sirtuins
As in the case of the HDAC family of deacetylases, theorientation is inverted.
The mechanism by which Sir2-AF1 catalyzes deacety- identification of small-molecule inhibitors of the sirtuin
family of deacetylases would provide a useful tool withlation is not obvious from this structure. The NAD bind-
ing pocket contains three sites: site A, which binds the which to dissect their biological function in a variety
of systems. This is particularly critical for studying theadenine-ribose moiety; site B, which binds the nicotin-
amide-ribose moiety; and site C, which is deep within function of the sirtuins in metazoans since these are
completely uncharacterized. Although a nonhydrolyz-the pocket and does not contact the NAD directly in the
crystal structure. However, the residues in site C are able NAD analog has been used as an effective inhibitor
of sirtuin deacetylase activity [93], such molecules un-very well conserved, and mutation of these sites disrupts
enzymatic activity, suggesting that this region is in- doubtedly will nonspecifically inhibit other NAD-depen-
dent enzymes. We have successfully identified a class ofvolved in the catalytic process. The binding site for the
acetyl-lysine is not apparent; it could not access the cell-permeable small-molecule inhibitors of both human
and yeast sirtuins [3]. These inhibitors contain a 2-NAD binding pocket without disrupting the NAD. Thus,
it is hypothesized that the NAD molecule changes con- hydroxyl-1-napthol moiety that is sufficient for inhibition,
and thus it may be possible to produce specific inhibi-figuration such that the nicotinamide moves into the C
site and thus frees the B site to bind the acetyl-lysine. tors for the seven human sirtuins by constructing ana-
logs based on this structure. These small-molecule sir-A serine residue in the C site could act as a nucleophile
to cleave the nicotinamide from the NAD. The serine- tuin inhibitors could be used to study the roles of sirtuins
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